Cell Transformation, Neoplastic
"Cell Transformation, Neoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
MeSH Number(s)
C04.697.152
C23.550.727.152
Concept/Terms
Cell Transformation, Neoplastic- Cell Transformation, Neoplastic
- Cell Transformations, Neoplastic
- Neoplastic Cell Transformations
- Transformations, Neoplastic Cell
- Neoplastic Transformation, Cell
- Cell Neoplastic Transformation
- Cell Neoplastic Transformations
- Neoplastic Transformations, Cell
- Transformation, Cell Neoplastic
- Transformations, Cell Neoplastic
- Oncogenesis
- Oncogeneses
- Tumorigenesis
- Tumorigeneses
- Tumorigenic Transformation
- Transformation, Tumorigenic
- Transformations, Tumorigenic
- Tumorigenic Transformations
- Neoplastic Cell Transformation
- Transformation, Neoplastic Cell
Below are MeSH descriptors whose meaning is more general than "Cell Transformation, Neoplastic".
Below are MeSH descriptors whose meaning is more specific than "Cell Transformation, Neoplastic".
This graph shows the total number of publications written about "Cell Transformation, Neoplastic" by people in Harvard Catalyst Profiles by year, and whether "Cell Transformation, Neoplastic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 13 | 17 | 30 |
1995 | 13 | 18 | 31 |
1996 | 13 | 11 | 24 |
1997 | 16 | 10 | 26 |
1998 | 12 | 16 | 28 |
1999 | 15 | 13 | 28 |
2000 | 14 | 22 | 36 |
2001 | 15 | 20 | 35 |
2002 | 25 | 27 | 52 |
2003 | 26 | 25 | 51 |
2004 | 31 | 32 | 63 |
2005 | 30 | 23 | 53 |
2006 | 20 | 36 | 56 |
2007 | 39 | 34 | 73 |
2008 | 33 | 22 | 55 |
2009 | 26 | 26 | 52 |
2010 | 35 | 37 | 72 |
2011 | 37 | 48 | 85 |
2012 | 67 | 49 | 116 |
2013 | 53 | 40 | 93 |
2014 | 42 | 38 | 80 |
2015 | 32 | 41 | 73 |
2016 | 42 | 35 | 77 |
2017 | 37 | 37 | 74 |
2018 | 29 | 31 | 60 |
2019 | 17 | 25 | 42 |
2020 | 19 | 23 | 42 |
2021 | 16 | 21 | 37 |
2022 | 0 | 28 | 28 |
2023 | 4 | 18 | 22 |
2024 | 0 | 4 | 4 |
Below are the most recent publications written about "Cell Transformation, Neoplastic" by people in Profiles.
-
EZH2-interacting lncRNAs contribute to gastric tumorigenesis; a review on the mechanisms of action. Mol Biol Rep. 2024 Feb 23; 51(1):334.
-
Malignant tumor cells engender second membrane-lined organelles for self-protection and tumor progression. Proc Natl Acad Sci U S A. 2024 Feb 06; 121(6):e2317141121.
-
Genetically-engineered mouse models of small cell lung cancer: the next generation. Oncogene. 2024 Feb; 43(7):457-469.
-
TLR9 Monotherapy in Immune-Competent Mice Suppresses Orthotopic Prostate Tumor Development. Cells. 2024 01 02; 13(1).
-
The BRD4-NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma. Cancer Res. 2023 12 01; 83(23):3846-3860.
-
Alveolar type I cells can give rise to KRAS-induced lung adenocarcinoma. Cell Rep. 2023 12 26; 42(12):113286.
-
Functional screening of amplification outlier oncogenes in organoid models of early tumorigenesis. Cell Rep. 2023 11 28; 42(11):113355.
-
Exploiting signaling rewiring in cancer cells with co-existing oncogenic drivers. Mol Oncol. 2023 Nov; 17(11):2215-2217.
-
Pan-cancer proteogenomics connects oncogenic drivers to functional states. Cell. 2023 08 31; 186(18):3921-3944.e25.
-
Management of Richter transformation. Clin Adv Hematol Oncol. 2023 08; 21(8):449-451.